MedTrace Logo

Inflammation and Clotting Abnormalities in Aneurysmal Coronary Artery Disease

NCT05183373 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2022-01-10

No results posted yet for this study

Summary

The main objective of the CARE-ANEURYSM project is to evaluate inflammation and clotting abnormalities in patients with aneurysmal coronary artery disease in relation to patients with abdominal aortic aneurysm or coronary artery disease (acting as controls).

Conditions

  • Coronary Artery Aneurysm
  • Abdominal Aortic Aneurysm
  • Coronary Disease

Interventions

OTHER

Evaluation of inflammation and clotting

Evaluation of inflammation biomarkers (such as 8-isoprostane, Il-6) and fibrin clot properties (such as clot lysis time, clot permeability)

Sponsors & Collaborators

  • Jagiellonian University

    collaborator OTHER

  • National Science Centre, Poland

    collaborator OTHER_GOV

  • John Paul II Hospital, Krakow

    lead OTHER

Principal Investigators

  • Piotr Musiałek, MD, DPhil · John Paul II Hospital, Krakow

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-10
Primary Completion
2024-09-30
Completion
2025-09-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05183373 on ClinicalTrials.gov